[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@ContractPharma Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::19774555.png) @ContractPharma Contract Pharma

Contract Pharma posts on X about vivo, acquisition, $heide, $8750t the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::19774555/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::19774555/c:line/m:interactions.svg)

- X Week XXXXX -X%
- X Month XXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +133%

### Mentions: X [#](/creator/twitter::19774555/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::19774555/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month XX -XX%
- X Months XXX +106%
- X Year XXX +162%

### Followers: XXXXXX [#](/creator/twitter::19774555/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::19774555/c:line/m:followers.svg)

- X Week XXXXXX +0.09%
- X Month XXXXXX +0.34%
- X Months XXXXXX +2.40%
- X Year XXXXXX +4.40%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::19774555/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::19774555/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::19774555/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [technology brands](/list/technology-brands)  XXXX% [finance](/list/finance)  XXXX%

**Social topic influence**
[vivo](/topic/vivo) 9.52%, [acquisition](/topic/acquisition) 4.76%, [$heide](/topic/$heide) 4.76%, [$8750t](/topic/$8750t) 4.76%, [$4568t](/topic/$4568t) 4.76%, [$6417t](/topic/$6417t) 4.76%, [gsk plc](/topic/gsk-plc) XXXX%

**Top assets mentioned**
[GSK plc (GSK)](/topic/gsk-plc)
### Top Social Posts [#](/creator/twitter::19774555/posts)
---
Top posts by engagements in the last XX hours

"Lonza Group AG has broadened its suite of cell and gene therapy manufacturing solutions with the launch of two new products: TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium. ➡ #pharmanews #CGTmanufacturing #CGT"  
[X Link](https://x.com/ContractPharma/status/1975259095339868274) [@ContractPharma](/creator/x/ContractPharma) 2025-10-06T17:57Z 14.1K followers, 1538 engagements


"Thermo Fisher Scientific has launched Gibco Efficient-Pro Medium (+) Insulin a next-generation medium designed to increase titers to maximize productivity and performance of insulin-dependent CHO cell lines. ➡ #pharmanews #insulin #thermofisher"  
[X Link](https://x.com/ContractPharma/status/1967663025965416889) [@ContractPharma](/creator/x/ContractPharma) 2025-09-15T18:53Z 14.1K followers, XXX engagements


"Bristol Myers Squibb has agreed to acquire Orbital Therapeutics a privately held biotechnology company pioneering a new generation of RNA medicines. ➡ #pharmanews #RNA #biotech"  
[X Link](https://x.com/ContractPharma/status/1976647069809983756) [@ContractPharma](/creator/x/ContractPharma) 2025-10-10T13:52Z 14.1K followers, XXX engagements


"Bristol Myers Squibb has agreed to acquire Orbital Therapeutics a privately held biotechnology company pioneering a new generation of RNA medicines that reprogram the immune system in vivo. ➡ #pharmanews #biotech #RNAmedicines"  
[X Link](https://x.com/ContractPharma/status/1979172357592748205) [@ContractPharma](/creator/x/ContractPharma) 2025-10-17T13:07Z 14.1K followers, XXX engagements


"Bristol Myers Squibb has agreed to acquire Orbital Therapeutics a privately held biotechnology company pioneering a new generation of RNA medicines that reprogram the immune system in vivo. ➡ #pharmanews #biotech #RNAmedicines"  
[X Link](https://x.com/ContractPharma/status/1977726086021571037) [@ContractPharma](/creator/x/ContractPharma) 2025-10-13T13:20Z 14.1K followers, XXX engagements


"Novo Nordisk has agreed to acquire Akero Therapeutics Inc. a publicly held clinical-stage company developing treatments for serious metabolic diseases for $XXX billion in cash at closing with a contingent value right of $XXX million. ➡ #pharmanews #acquisition #metabolicdiseases"  
[X Link](https://x.com/ContractPharma/status/1980622443061391827) [@ContractPharma](/creator/x/ContractPharma) 2025-10-21T13:09Z 14.1K followers, XXX engagements


"BioMed X an innovation hub for pharma has introduced a new research team at its Heidelberg institute for multispecific biologics in the field of immuno-oncology in collaboration with Daiichi Sankyo. ➡ #pharmanews #oncology #biologics"  
[X Link](https://x.com/ContractPharma/status/1981359819563934058) [@ContractPharma](/creator/x/ContractPharma) 2025-10-23T13:59Z 14.1K followers, XXX engagements


"GSK plc has announced FDA approval of Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adults with relapsed or refractory multiple myeloma who have received at least two prior therapies. ➡ #pharmanews #FDA #myeloma"  
[X Link](https://x.com/ContractPharma/status/1981794676836372691) [@ContractPharma](/creator/x/ContractPharma) 2025-10-24T18:47Z 14.1K followers, XXX engagements